SPL 1.06% $1.43 starpharma holdings limited

Are Acorn the culprit

  1. 7,228 Posts.
    lightbulb Created with Sketch. 203
    The more I think about - the more I am convinced Acorn are continuing to sell down holdings in Starpharma

    My reasoning behind this

    The spike up to 54 cents this week in my opinion was not on Ansell's results

    The 300 k was taken out so easily by a determined buyer and yet there was continual supply on the ask. Pity I have run out of moolah or would absorb all the shares being sold by Acorn.

    Since Monday share price has fallen more than 10 per cent

    Share market up as I type more than 140 points

    Can hardly wait for phase 1 clinical trial update

    Should put a rocket under share price

    Above is my opinion and should not be construed as investment advice
    Last edited by antibotter: 13/02/15
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Mkt cap $525.3M
Open High Low Value Volume
$1.41 $1.45 $1.40 $335.4K 235.8K

Buyers (Bids)

No. Vol. Price($)
2 4507 $1.42

Sellers (Offers)

Price($) Vol. No.
$1.43 993 1
Last update - 16.10pm 11/12/2018 (20 minute delay) ?
0.02 ( 0.32 %)
Open High   Low Volume
$1.42 $1.45   $1.40 46102
Last updated 15.57pm 11/12/2018 (live) ?
SPL (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.